Effects of a 3-Week In-Hospital Body Weight Reduction Program on Cardiovascular Risk Factors, Muscle Performance, and Fatigue: A Retrospective Study in a Population of Obese Adults with or without Metabolic Syndrome
Background. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. Objectives and Methods. The aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in...
Saved in:
Published in | Nutrients Vol. 12; no. 5; p. 1495 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
21.05.2020
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 2072-6643 2072-6643 |
DOI | 10.3390/nu12051495 |
Cover
Abstract | Background. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. Objectives and Methods. The aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in a large population of obese subjects with and without metabolic syndrome (n = 1922; 222 men and 1700 women, age range 18–83 yr). Outcomes such as body mass index (BMI), total (TOT) and HDL cholesterol, systolic and diastolic blood pressures (SBP and DBP, respectively), coronary heart disease (CHD) score, fatigue severity score (FSS), and stair climbing test (SCT) time were evaluated before and after the intervention (Δ). A sex-, BMI-, and age-related stratification of the obese population with or without metabolic syndrome was applied. Results. When compared to obese subjects without metabolic syndrome, at the basal conditions, obese subjects had a poorer cardiometabolic profile, as demonstrated by higher triglycerides, TOT-cholesterol, DBP, SBP, and CHD score, and a more compromised muscle performance (evaluated by SCT), associated with more perception of fatigue (measured by FSS). Nevertheless, obese subjects with metabolic syndrome obtained more benefits from BWRP than those without metabolic syndrome for some outcomes (i.e., ΔTOT-cholesterol, ΔSBP, and ΔCHD score). Despite these differences, the BWRP-induced weight loss was similar between the two groups (i.e., ΔBMI) as well as the gain of muscle performance (i.e., ΔSCT) and the reduction of fatigue (i.e., ΔFSS). Interestingly, the potentially deleterious fall in HDL-cholesterol levels after BWRP was less evident in obese subjects with metabolic syndrome than those without metabolic syndrome. When pooling all data, the ΔCHD score was associated with age, sex, and metabolic syndrome. The remaining outcomes, such as ΔBMI, ΔFSS, and ΔSCT time, were associated with sex and age but not with metabolic syndrome. Finally, ΔBMI was positively correlated with ΔCHD score, ΔFSS, and ΔSCT time in both obese subjects without metabolic syndrome and obese subjects with metabolic syndrome. Conclusions. When comparing obese subjects undergoing a BWRP, metabolic syndrome is not a negative predictive factor affecting the effectiveness of this intervention in terms of weight loss, muscle performance, and psychological well-being. |
---|---|
AbstractList | Background. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. Objectives and Methods. The aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in a large population of obese subjects with and without metabolic syndrome (n = 1922; 222 men and 1700 women, age range 18–83 yr). Outcomes such as body mass index (BMI), total (TOT) and HDL cholesterol, systolic and diastolic blood pressures (SBP and DBP, respectively), coronary heart disease (CHD) score, fatigue severity score (FSS), and stair climbing test (SCT) time were evaluated before and after the intervention (Δ). A sex-, BMI-, and age-related stratification of the obese population with or without metabolic syndrome was applied. Results. When compared to obese subjects without metabolic syndrome, at the basal conditions, obese subjects had a poorer cardiometabolic profile, as demonstrated by higher triglycerides, TOT-cholesterol, DBP, SBP, and CHD score, and a more compromised muscle performance (evaluated by SCT), associated with more perception of fatigue (measured by FSS). Nevertheless, obese subjects with metabolic syndrome obtained more benefits from BWRP than those without metabolic syndrome for some outcomes (i.e., ΔTOT-cholesterol, ΔSBP, and ΔCHD score). Despite these differences, the BWRP-induced weight loss was similar between the two groups (i.e., ΔBMI) as well as the gain of muscle performance (i.e., ΔSCT) and the reduction of fatigue (i.e., ΔFSS). Interestingly, the potentially deleterious fall in HDL-cholesterol levels after BWRP was less evident in obese subjects with metabolic syndrome than those without metabolic syndrome. When pooling all data, the ΔCHD score was associated with age, sex, and metabolic syndrome. The remaining outcomes, such as ΔBMI, ΔFSS, and ΔSCT time, were associated with sex and age but not with metabolic syndrome. Finally, ΔBMI was positively correlated with ΔCHD score, ΔFSS, and ΔSCT time in both obese subjects without metabolic syndrome and obese subjects with metabolic syndrome. Conclusions. When comparing obese subjects undergoing a BWRP, metabolic syndrome is not a negative predictive factor affecting the effectiveness of this intervention in terms of weight loss, muscle performance, and psychological well-being. Background. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. Objectives and Methods. The aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in a large population of obese subjects with and without metabolic syndrome ( n = 1922; 222 men and 1700 women, age range 18–83 yr). Outcomes such as body mass index (BMI), total (TOT) and HDL cholesterol, systolic and diastolic blood pressures (SBP and DBP, respectively), coronary heart disease (CHD) score, fatigue severity score (FSS), and stair climbing test (SCT) time were evaluated before and after the intervention (Δ). A sex-, BMI-, and age-related stratification of the obese population with or without metabolic syndrome was applied. Results. When compared to obese subjects without metabolic syndrome, at the basal conditions, obese subjects had a poorer cardiometabolic profile, as demonstrated by higher triglycerides, TOT-cholesterol, DBP, SBP, and CHD score, and a more compromised muscle performance (evaluated by SCT), associated with more perception of fatigue (measured by FSS). Nevertheless, obese subjects with metabolic syndrome obtained more benefits from BWRP than those without metabolic syndrome for some outcomes (i.e., ΔTOT-cholesterol, ΔSBP, and ΔCHD score). Despite these differences, the BWRP-induced weight loss was similar between the two groups (i.e., ΔBMI) as well as the gain of muscle performance (i.e., ΔSCT) and the reduction of fatigue (i.e., ΔFSS). Interestingly, the potentially deleterious fall in HDL-cholesterol levels after BWRP was less evident in obese subjects with metabolic syndrome than those without metabolic syndrome. When pooling all data, the ΔCHD score was associated with age, sex, and metabolic syndrome. The remaining outcomes, such as ΔBMI, ΔFSS, and ΔSCT time, were associated with sex and age but not with metabolic syndrome. Finally, ΔBMI was positively correlated with ΔCHD score, ΔFSS, and ΔSCT time in both obese subjects without metabolic syndrome and obese subjects with metabolic syndrome. Conclusions. When comparing obese subjects undergoing a BWRP, metabolic syndrome is not a negative predictive factor affecting the effectiveness of this intervention in terms of weight loss, muscle performance, and psychological well-being. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat.BACKGROUNDIn clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat.The aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in a large population of obese subjects with and without metabolic syndrome (n = 1922; 222 men and 1700 women, age range 18-83 yr). Outcomes such as body mass index (BMI), total (TOT) and HDL cholesterol, systolic and diastolic blood pressures (SBP and DBP, respectively), coronary heart disease (CHD) score, fatigue severity score (FSS), and stair climbing test (SCT) time were evaluated before and after the intervention (Δ). A sex-, BMI-, and age-related stratification of the obese population with or without metabolic syndrome was applied.OBJECTIVES AND METHODSThe aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in a large population of obese subjects with and without metabolic syndrome (n = 1922; 222 men and 1700 women, age range 18-83 yr). Outcomes such as body mass index (BMI), total (TOT) and HDL cholesterol, systolic and diastolic blood pressures (SBP and DBP, respectively), coronary heart disease (CHD) score, fatigue severity score (FSS), and stair climbing test (SCT) time were evaluated before and after the intervention (Δ). A sex-, BMI-, and age-related stratification of the obese population with or without metabolic syndrome was applied.When compared to obese subjects without metabolic syndrome, at the basal conditions, obese subjects had a poorer cardiometabolic profile, as demonstrated by higher triglycerides, TOT-cholesterol, DBP, SBP, and CHD score, and a more compromised muscle performance (evaluated by SCT), associated with more perception of fatigue (measured by FSS). Nevertheless, obese subjects with metabolic syndrome obtained more benefits from BWRP than those without metabolic syndrome for some outcomes (i.e., ΔTOT-cholesterol, ΔSBP, and ΔCHD score). Despite these differences, the BWRP-induced weight loss was similar between the two groups (i.e., ΔBMI) as well as the gain of muscle performance (i.e., ΔSCT) and the reduction of fatigue (i.e., ΔFSS). Interestingly, the potentially deleterious fall in HDL-cholesterol levels after BWRP was less evident in obese subjects with metabolic syndrome than those without metabolic syndrome. When pooling all data, the ΔCHD score was associated with age, sex, and metabolic syndrome. The remaining outcomes, such as ΔBMI, ΔFSS, and ΔSCT time, were associated with sex and age but not with metabolic syndrome. Finally, ΔBMI was positively correlated with ΔCHD score, ΔFSS, and ΔSCT time in both obese subjects without metabolic syndrome and obese subjects with metabolic syndrome.RESULTSWhen compared to obese subjects without metabolic syndrome, at the basal conditions, obese subjects had a poorer cardiometabolic profile, as demonstrated by higher triglycerides, TOT-cholesterol, DBP, SBP, and CHD score, and a more compromised muscle performance (evaluated by SCT), associated with more perception of fatigue (measured by FSS). Nevertheless, obese subjects with metabolic syndrome obtained more benefits from BWRP than those without metabolic syndrome for some outcomes (i.e., ΔTOT-cholesterol, ΔSBP, and ΔCHD score). Despite these differences, the BWRP-induced weight loss was similar between the two groups (i.e., ΔBMI) as well as the gain of muscle performance (i.e., ΔSCT) and the reduction of fatigue (i.e., ΔFSS). Interestingly, the potentially deleterious fall in HDL-cholesterol levels after BWRP was less evident in obese subjects with metabolic syndrome than those without metabolic syndrome. When pooling all data, the ΔCHD score was associated with age, sex, and metabolic syndrome. The remaining outcomes, such as ΔBMI, ΔFSS, and ΔSCT time, were associated with sex and age but not with metabolic syndrome. Finally, ΔBMI was positively correlated with ΔCHD score, ΔFSS, and ΔSCT time in both obese subjects without metabolic syndrome and obese subjects with metabolic syndrome.When comparing obese subjects undergoing a BWRP, metabolic syndrome is not a negative predictive factor affecting the effectiveness of this intervention in terms of weight loss, muscle performance, and psychological well-being.CONCLUSIONSWhen comparing obese subjects undergoing a BWRP, metabolic syndrome is not a negative predictive factor affecting the effectiveness of this intervention in terms of weight loss, muscle performance, and psychological well-being. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. The aim of the present study was that to investigate the effectiveness of a 3-week in-hospital body weight reduction program (BWRP) in a large population of obese subjects with and without metabolic syndrome ( = 1922; 222 men and 1700 women, age range 18-83 yr). Outcomes such as body mass index (BMI), total (TOT) and HDL cholesterol, systolic and diastolic blood pressures (SBP and DBP, respectively), coronary heart disease (CHD) score, fatigue severity score (FSS), and stair climbing test (SCT) time were evaluated before and after the intervention (Δ). A sex-, BMI-, and age-related stratification of the obese population with or without metabolic syndrome was applied. When compared to obese subjects without metabolic syndrome, at the basal conditions, obese subjects had a poorer cardiometabolic profile, as demonstrated by higher triglycerides, TOT-cholesterol, DBP, SBP, and CHD score, and a more compromised muscle performance (evaluated by SCT), associated with more perception of fatigue (measured by FSS). Nevertheless, obese subjects with metabolic syndrome obtained more benefits from BWRP than those without metabolic syndrome for some outcomes (i.e., ΔTOT-cholesterol, ΔSBP, and ΔCHD score). Despite these differences, the BWRP-induced weight loss was similar between the two groups (i.e., ΔBMI) as well as the gain of muscle performance (i.e., ΔSCT) and the reduction of fatigue (i.e., ΔFSS). Interestingly, the potentially deleterious fall in HDL-cholesterol levels after BWRP was less evident in obese subjects with metabolic syndrome than those without metabolic syndrome. When pooling all data, the ΔCHD score was associated with age, sex, and metabolic syndrome. The remaining outcomes, such as ΔBMI, ΔFSS, and ΔSCT time, were associated with sex and age but not with metabolic syndrome. Finally, ΔBMI was positively correlated with ΔCHD score, ΔFSS, and ΔSCT time in both obese subjects without metabolic syndrome and obese subjects with metabolic syndrome. When comparing obese subjects undergoing a BWRP, metabolic syndrome is not a negative predictive factor affecting the effectiveness of this intervention in terms of weight loss, muscle performance, and psychological well-being. |
Author | Cicolini, Sabrina Caroli, Diana Cella, Silvano G. Sartorio, Alessandro Rigamonti, Antonello E. Scacchi, Massimo De Col, Alessandra |
AuthorAffiliation | 3 Division of General Medicine, Istituto Auxologico Italiano, IRCCS, 28824 Verbania, Italy 2 Experimental Laboratory for Auxo-endocrinological Research, Istituto Auxologico Italiano, IRCCS, 28824 Verbania, Italy; s.cicolini@auxologico.it (S.C.); d.caroli@auxologico.it (D.C.); a.decol@auxologico.it (A.D.C.); sartorio@auxologico.it (A.S.) 1 Department of Clinical Sciences and Community Health, University of Milan, 20129 Milan, Italy; massimo.scacchi@unimi.it (M.S.); silvano.cella@unimi.it (S.G.C.) 4 Division of Auxology and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, 28824 Verbania, Italy |
AuthorAffiliation_xml | – name: 2 Experimental Laboratory for Auxo-endocrinological Research, Istituto Auxologico Italiano, IRCCS, 28824 Verbania, Italy; s.cicolini@auxologico.it (S.C.); d.caroli@auxologico.it (D.C.); a.decol@auxologico.it (A.D.C.); sartorio@auxologico.it (A.S.) – name: 3 Division of General Medicine, Istituto Auxologico Italiano, IRCCS, 28824 Verbania, Italy – name: 4 Division of Auxology and Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, 28824 Verbania, Italy – name: 1 Department of Clinical Sciences and Community Health, University of Milan, 20129 Milan, Italy; massimo.scacchi@unimi.it (M.S.); silvano.cella@unimi.it (S.G.C.) |
Author_xml | – sequence: 1 givenname: Antonello E. orcidid: 0000-0002-2489-9108 surname: Rigamonti fullname: Rigamonti, Antonello E. – sequence: 2 givenname: Sabrina orcidid: 0000-0003-1795-7848 surname: Cicolini fullname: Cicolini, Sabrina – sequence: 3 givenname: Diana surname: Caroli fullname: Caroli, Diana – sequence: 4 givenname: Alessandra surname: De Col fullname: De Col, Alessandra – sequence: 5 givenname: Massimo orcidid: 0000-0002-4624-9114 surname: Scacchi fullname: Scacchi, Massimo – sequence: 6 givenname: Silvano G. surname: Cella fullname: Cella, Silvano G. – sequence: 7 givenname: Alessandro orcidid: 0000-0002-9620-4133 surname: Sartorio fullname: Sartorio, Alessandro |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32455545$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1PFDEUhicGI4jc-ANME2-MYbTTr5nhwmTdgJBA2ICGy0mnc2a3MNOu_Vizv9S_YxcQkZjYm9OkT9_ztud9mW0ZayDLXhf4A6U1_mhiQTAvWM2fZTsElyQXgtGtR_vtbM_7a7xZJS4FfZFtU8I454zvZD8P-x5U8Mj2SCKaXwHcoBOTH1u_1EEO6LPt1ugK9HwR0AV0UQVtDZo5O3dyRGk7la7TdiW9ioN06EL7G3QkVbDO76Oz6NUAaAaut26URsE-kqZLQNDzCAdokkSDS82SCb0CdBli6qdNMjOzy6R42y6ZO2_BA5p0cUhmf-iwQNbdVhsDOoMgWztohS7XpnN2hFfZ814OHvbu62727ejw6_Q4Pz3_cjKdnOaK0TrkAqCkgingLS56CbyXQvZUgcCqAsJqWZadAgqMiJpzwquC96wsCWDZSs7obvbpTncZ2xESaoKTQ7N0epRu3Vipm79PjF40c7tqSlIxgesk8O5ewNnvEXxoRu0VDIM0YKNvCC-KosYVLv6PMlzSQjBRJfTtE_TaRmfST2wowUiJK56oN4_NP7j-HY8EvL8DVBqRd9A_IAVuNvFr_sQvwfgJrFKCNvNLD9fDv678Ah8w3wM |
CitedBy_id | crossref_primary_10_3389_fnut_2023_1203925 crossref_primary_10_3390_jcm11164677 crossref_primary_10_1111_jog_15904 crossref_primary_10_3389_fnagi_2022_1054941 crossref_primary_10_3390_jcm9113596 crossref_primary_10_29254_2077_4214_2022_3_166_147_159 crossref_primary_10_1038_s41591_024_03384_x crossref_primary_10_3389_fnut_2022_840018 crossref_primary_10_3310_nihropenres_13315_1 crossref_primary_10_3310_nihropenres_13315_2 crossref_primary_10_3389_fnut_2021_678788 crossref_primary_10_3390_nu13103362 crossref_primary_10_7570_jomes21049 crossref_primary_10_1038_s41598_022_09096_x crossref_primary_10_3390_jcm11113175 crossref_primary_10_3390_ijerph192315492 |
Cites_doi | 10.1111/j.1464-5491.2006.01858.x 10.1677/joe.0.1660529 10.1016/j.amjmed.2014.06.035 10.1007/s12017-008-8032-3 10.1089/jmf.2010.1202 10.1002/mnfr.201500272 10.1111/j.1463-1326.2012.01571.x 10.1161/01.CIR.97.18.1837 10.3389/fcvm.2018.00135 10.3390/ijms20030647 10.1186/1477-7525-11-32 10.1038/sj.ijo.0802433 10.1007/s12263-009-0110-0 10.5664/jcsm.26511 10.1007/BF03351039 10.1016/S0140-6736(05)66378-7 10.1007/s11906-018-0837-3 10.1007/s42000-018-0049-x 10.1001/archinte.165.8.910 10.1530/EJE-11-0312 10.1038/s41574-018-0062-9 10.7762/cnr.2015.4.2.69 10.1016/j.arr.2016.09.008 10.1186/1477-7525-5-12 10.3390/nu11061240 10.1007/BF03324999 10.1111/obr.12241 10.3390/nu12010208 10.1186/1479-5868-10-135 10.1038/sj.ejcn.1601235 10.1016/j.ypmed.2017.04.022 10.1093/bmb/ldr002 10.3109/17477160903111706 10.1590/1414-431x20176432 10.3402/fnr.v59.29678 10.1007/s11136-011-0009-2 10.1016/j.puhe.2016.08.009 10.1007/s11883-005-0030-4 10.1016/j.clnesp.2018.08.007 10.1016/j.bpobgyn.2016.01.006 |
ContentType | Journal Article |
Copyright | 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 by the authors. 2020 |
Copyright_xml | – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 by the authors. 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM |
DOI | 10.3390/nu12051495 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Physical Education Index ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA CrossRef Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2072-6643 |
ExternalDocumentID | PMC7284609 32455545 10_3390_nu12051495 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAWTL AAYXX ABUWG ACIWK ACPRK AENEX AFKRA AFRAH AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS APEBS BENPR BPHCQ BVXVI CCPQU CITATION DIK E3Z EBD ECGQY EIHBH ESTFP EYRJQ F5P FYUFA GX1 HMCUK HYE KQ8 LK8 M1P M48 MODMG M~E OK1 P2P P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 UKHRP CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7TS 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c439t-6ee7364ce5b01fae5fa6af3ce60c8e249a77dce3e42695525815f4772e0aba543 |
IEDL.DBID | M48 |
ISSN | 2072-6643 |
IngestDate | Thu Aug 21 18:16:20 EDT 2025 Fri Sep 05 13:01:55 EDT 2025 Sun Aug 24 03:54:18 EDT 2025 Fri Jul 25 10:43:50 EDT 2025 Mon Jul 21 06:03:51 EDT 2025 Thu Apr 24 22:55:09 EDT 2025 Tue Jul 01 02:30:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | metabolic syndrome stair climbing test body mass index fatigue severity score cardiovascular risk factors body weight reduction program obesity |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-6ee7364ce5b01fae5fa6af3ce60c8e249a77dce3e42695525815f4772e0aba543 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9620-4133 0000-0002-4624-9114 0000-0002-2489-9108 0000-0003-1795-7848 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/nu12051495 |
PMID | 32455545 |
PQID | 2406427085 |
PQPubID | 2032353 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7284609 proquest_miscellaneous_2511190801 proquest_miscellaneous_2407316468 proquest_journals_2406427085 pubmed_primary_32455545 crossref_primary_10_3390_nu12051495 crossref_citationtrail_10_3390_nu12051495 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20200521 |
PublicationDateYYYYMMDD | 2020-05-21 |
PublicationDate_xml | – month: 5 year: 2020 text: 20200521 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Nutrients |
PublicationTitleAlternate | Nutrients |
PublicationYear | 2020 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Nystoriak (ref_31) 2018; 5 Rossoni (ref_4) 2000; 166 Pritchett (ref_7) 2005; 7 Polyzos (ref_34) 2018; 17 Dunkley (ref_16) 2012; 14 Rigamonti (ref_5) 2015; 59 Bassi (ref_15) 2014; 127 Foley (ref_40) 2008; 10 Sartorio (ref_23) 2003; 28 Saladini (ref_32) 2018; 20 Jovanovski (ref_33) 2015; 4 Fiorini (ref_19) 2016; 141 Sartorio (ref_12) 2003; 16 Sartorio (ref_13) 2001; 55 Alberti (ref_21) 2006; 23 Bartolomucci (ref_2) 2009; 4 Bianchi (ref_29) 2018; 28 Elbers (ref_28) 2011; 21 Lv (ref_14) 2017; 100 Wilson (ref_22) 1998; 97 Impellizzeri (ref_24) 2013; 11 Norman (ref_6) 2016; 37 Sartorio (ref_25) 2001; 14 Eime (ref_41) 2013; 10 Batsis (ref_42) 2018; 14 Lim (ref_35) 2005; 165 Resnick (ref_36) 2006; 2 Legato (ref_17) 1997; 42 Sartorio (ref_11) 2003; 16 ref_43 Lee (ref_38) 2011; 14 Cordeiro (ref_39) 2017; 50 Williams (ref_18) 2014; 16 Han (ref_20) 2011; 97 Eckel (ref_1) 2005; 365 Varni (ref_37) 2010; 5 ref_9 ref_8 Sartorio (ref_10) 2003; 8 Kalinkovich (ref_44) 2017; 35 Apostolopoulos (ref_30) 2015; 60 Rigamonti (ref_3) 2011; 165 Hjollund (ref_27) 2007; 5 Sartorio (ref_26) 2001; 24 |
References_xml | – volume: 23 start-page: 469 year: 2006 ident: ref_21 article-title: Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation publication-title: Diabet. Med. doi: 10.1111/j.1464-5491.2006.01858.x – volume: 166 start-page: 529 year: 2000 ident: ref_4 article-title: Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats publication-title: J. Endocrinol. doi: 10.1677/joe.0.1660529 – volume: 127 start-page: 1242.e1 year: 2014 ident: ref_15 article-title: Lifestyle Modification for Metabolic Syndrome: A Systematic Review publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2014.06.035 – volume: 10 start-page: 67 year: 2008 ident: ref_40 article-title: Neuroplasticity of Dopamine Circuits After Exercise: Implications for Central Fatigue publication-title: Neuromol. Med. doi: 10.1007/s12017-008-8032-3 – volume: 14 start-page: 386 year: 2011 ident: ref_38 article-title: Effects of Coenzyme Q10 on Arterial Stiffness, Metabolic Parameters, and Fatigue in Obese Subjects: A Double-Blind Randomized Controlled Study publication-title: J. Med. Food doi: 10.1089/jmf.2010.1202 – volume: 60 start-page: 43 year: 2015 ident: ref_30 article-title: The complex immunological and inflammatory network of adipose tissue in obesity publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.201500272 – volume: 16 start-page: 262 year: 2003 ident: ref_11 article-title: Short-term effects of two integrated, non-pharmacological body weight reduction programs on coronary heart disease risk factors in young obese patients publication-title: Diabetes Nutr. Metab. – volume: 14 start-page: 616 year: 2012 ident: ref_16 article-title: Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: Systematic review and mixed treatment comparison meta-analysis publication-title: Diabetes Obes. Metab. doi: 10.1111/j.1463-1326.2012.01571.x – volume: 97 start-page: 1837 year: 1998 ident: ref_22 article-title: Prediction of coronary hearth disease using risk factor categories publication-title: Circulation doi: 10.1161/01.CIR.97.18.1837 – volume: 5 start-page: 135 year: 2018 ident: ref_31 article-title: Cardiovascular Effects and Benefits of Exercise publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2018.00135 – ident: ref_43 doi: 10.3390/ijms20030647 – volume: 11 start-page: 32 year: 2013 ident: ref_24 article-title: Psychometric properties of the Fatigue Severity Scale in obese patients publication-title: Health Qual. Life Outcomes doi: 10.1186/1477-7525-11-32 – volume: 28 start-page: 91 year: 2003 ident: ref_23 article-title: Influence of gender, age and BMI on lower limb muscular power output in a large population of obese men and women publication-title: Int. J. Obes. Relat. Metab. Disord. doi: 10.1038/sj.ijo.0802433 – volume: 4 start-page: 49 year: 2009 ident: ref_2 article-title: Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice publication-title: Genes Nutr. doi: 10.1007/s12263-009-0110-0 – volume: 2 start-page: 163 year: 2006 ident: ref_36 article-title: Cross-Sectional Relationship of Reported Fatigue to Obesity, Diet, and Physical Activity: Results From the Third National Health and Nutrition Examination Survey publication-title: J. Clin. Sleep Med. doi: 10.5664/jcsm.26511 – volume: 24 start-page: 393 year: 2001 ident: ref_26 article-title: Changes in motor control and muscle performance after a short-term body mass reduction program in obese subjects publication-title: J. Endocrinol. Investig. doi: 10.1007/BF03351039 – volume: 365 start-page: 1415 year: 2005 ident: ref_1 article-title: The metabolic syndrome publication-title: Lancet doi: 10.1016/S0140-6736(05)66378-7 – volume: 20 start-page: 39 year: 2018 ident: ref_32 article-title: Arterial Distensibility, Physical Activity, and the Metabolic Syndrome publication-title: Curr. Hypertens Rep. doi: 10.1007/s11906-018-0837-3 – volume: 17 start-page: 321 year: 2018 ident: ref_34 article-title: Sarcopenic obesity publication-title: Hormones doi: 10.1007/s42000-018-0049-x – volume: 165 start-page: 910 year: 2005 ident: ref_35 article-title: The Association of Obesity, Cytokine Levels, and Depressive Symptoms With Diverse Measures of Fatigue in Healthy Subjects publication-title: Arch. Intern. Med. doi: 10.1001/archinte.165.8.910 – volume: 165 start-page: 421 year: 2011 ident: ref_3 article-title: Effect of somatostatin infusion on peptide YY secretion: Studies in the acute and recovery phase of anorexia nervosa and in obesity publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-11-0312 – volume: 14 start-page: 513 year: 2018 ident: ref_42 article-title: Sarcopenic obesity in older adults: Aetiology, epidemiology and treatment strategies publication-title: Nat. Rev. Endocrinol. doi: 10.1038/s41574-018-0062-9 – volume: 4 start-page: 69 year: 2015 ident: ref_33 article-title: Carbohydrates and Endothelial Function: Is a Low-Carbohydrate Diet or a Low-Glycemic Index Diet Favourable for Vascular Health? publication-title: Clin. Nutr. Res. doi: 10.7762/cnr.2015.4.2.69 – volume: 16 start-page: 88 year: 2003 ident: ref_12 article-title: Short-term changes of fatigability and muscle performance in severe obese patients after an integrated body mass reduction program publication-title: Diabetes Nutr. Metab. – volume: 35 start-page: 200 year: 2017 ident: ref_44 article-title: Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis publication-title: Ageing Res. Rev. doi: 10.1016/j.arr.2016.09.008 – volume: 5 start-page: 12 year: 2007 ident: ref_27 article-title: Assessment of fatigue in chronic disease: A bibliographic study of fatigue measurement scales publication-title: Health Qual. Life Outcomes doi: 10.1186/1477-7525-5-12 – ident: ref_8 doi: 10.3390/nu11061240 – volume: 8 start-page: 107 year: 2003 ident: ref_10 article-title: Three-week integrated body weight reduction programme markedly improves performance and work capacity in severely obese patients publication-title: Eat. Weight. Disord. doi: 10.1007/BF03324999 – volume: 16 start-page: 171 year: 2014 ident: ref_18 article-title: Effectiveness of weight loss interventions—Is there a difference between men and women: A systematic review publication-title: Obes. Rev. doi: 10.1111/obr.12241 – ident: ref_9 doi: 10.3390/nu12010208 – volume: 10 start-page: 135 year: 2013 ident: ref_41 article-title: A systematic review of the psychological and social benefits of participation in sport for adults: Informing development of a conceptual model of health through sport publication-title: Int. J. Behav. Nutr. Phys. Act. doi: 10.1186/1479-5868-10-135 – volume: 55 start-page: 865 year: 2001 ident: ref_13 article-title: Short-term changes of cardiovascular risk factors after a non-pharmacological body weight reduction program publication-title: Eur. J. Clin. Nutr. doi: 10.1038/sj.ejcn.1601235 – volume: 100 start-page: 180 year: 2017 ident: ref_14 article-title: Behavioral lifestyle interventions for moderate and severe obesity: A systematic review publication-title: Prev. Med. doi: 10.1016/j.ypmed.2017.04.022 – volume: 97 start-page: 169 year: 2011 ident: ref_20 article-title: Obesity and weight management in the elderly publication-title: Br. Med. Bull. doi: 10.1093/bmb/ldr002 – volume: 5 start-page: 34 year: 2010 ident: ref_37 article-title: The PedsQL Multidimensional Fatigue Scale in pediatric obesity: Feasibility, reliability and validity publication-title: Int. J. Pediatr. Obes. doi: 10.3109/17477160903111706 – volume: 50 start-page: e6432 year: 2017 ident: ref_39 article-title: Physical exercise-induced fatigue: The role of serotonergic and dopaminergic systems publication-title: Braz. J. Med Biol. Res. doi: 10.1590/1414-431x20176432 – volume: 59 start-page: 29678 year: 2015 ident: ref_5 article-title: Anticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adults publication-title: Food Nutr. Res. doi: 10.3402/fnr.v59.29678 – volume: 21 start-page: 925 year: 2011 ident: ref_28 article-title: Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: A systematic review of measurement properties publication-title: Qual. Life Res. doi: 10.1007/s11136-011-0009-2 – volume: 42 start-page: 184 year: 1997 ident: ref_17 article-title: Gender-specific aspects of obesity publication-title: Int. J. Fertil. Women’s Med. – volume: 141 start-page: 26 year: 2016 ident: ref_19 article-title: The burden of chronic noncommunicable diseases in undocumented migrants: A 1-year survey of drugs dispensation by a non–governmental organization in Italy publication-title: Public Health doi: 10.1016/j.puhe.2016.08.009 – volume: 14 start-page: 51 year: 2001 ident: ref_25 article-title: Aerobic and anaerobic performance before and after a short-term body mass reduction program in obese subjects publication-title: Diabetes Nutr. Metab. – volume: 7 start-page: 95 year: 2005 ident: ref_7 article-title: Treatment of the metabolic syndrome: The impact of lifestyle modification publication-title: Curr. Atheroscler. Rep. doi: 10.1007/s11883-005-0030-4 – volume: 28 start-page: 21 year: 2018 ident: ref_29 article-title: Weight loss is a critical factor to reduce inflammation publication-title: Clin. Nutr. ESPEN doi: 10.1016/j.clnesp.2018.08.007 – volume: 37 start-page: 140 year: 2016 ident: ref_6 article-title: Metabolic syndrome, diet and exercise publication-title: Best Pract. Res. Clin. Obstet. Gynaecol. doi: 10.1016/j.bpobgyn.2016.01.006 |
SSID | ssj0000070763 |
Score | 2.3277652 |
Snippet | Background. In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. Objectives and... In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat. The aim of the present study... In clinical practice, there is the diffuse conviction that obese subjects with metabolic syndrome may be more difficult to treat.BACKGROUNDIn clinical... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1495 |
SubjectTerms | Adolescent Adult Age Aged Aged, 80 and over Angina pectoris Blood pressure Body Mass Index Cardiovascular disease Cardiovascular Diseases - complications Cholesterol Cholesterol, HDL - blood coronary disease Counseling Diabetes diastolic blood pressure elderly Exercise Fatigue - etiology Female Glucose Health risk assessment Heart attacks Heart Disease Risk Factors high density lipoprotein cholesterol Hospitals Humans Hypertension Male men Metabolic syndrome Metabolic Syndrome - complications Middle Aged muscle fatigue Muscles Obesity Physical fitness Retrospective Studies Risk factors Sexes Smoking Statistical analysis systolic blood pressure triacylglycerols Triglycerides Weight control weight control programs Weight Loss Weight Reduction Programs Well being women Young Adult |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9NAEF1Be-GCKOUjUNAgEBJSV_XXrm0uKK0aFaRWUaCit2i9GZeIsm5j-5Bfyt9hxnacBlBPjuKRM8rO7r4Zz74nxDsTZ3aWJzOZKNQywgClCSxKZVJPGUq56GvutjjTJ-fRlwt10RXcyq6tcrUmNgv1rLBcIz_gnScKYkIIn65vJKtG8dvVTkLjvtimJTihON8-PD4bT_oqS8Nmo8OWlzSk_P7A1X7AnN8sKHF7J_oHXv7dJXlr2xk9Eg87vAjDdoB3xD10j8Xu0FGu_GsJ76Hp4GxK47vid0tFXEKRg4FQMhMvfHZypQ0Ch8VsCd-bYihMmLOVRwXGbYsW0Mejje5UmMzLnzBqFXn24bQuyQUYr48a7INxMzKo5pc1foQhPbRaFKvDm8A9ikuYO3Jm3OuEsXOsRoAwZOqPErgSDMWiuRZ1BadYUWBezS187dgUnojz0fG3oxPZCTdIS_imkhoxDnVkUWWenxtUudEmDy1qzyZICZ-JY_pbQ-RztEoFKvFVHhHOR89kRkXhU7HlCofPBWCMnm-0tZmOI5tmGaVvuaaHpCFd0mggPqwGcWo7VnMW17iaUnbDAz5dD_hAvO1tr1suj_9a7a1iYdrN53K6jr6BeNPfppnIr1eMw6JubFgGLNLJHTaEbwmCESwYiGdtePWuELRVBO7oF-KNwOsNmAl8846b_2gYwWMCGdpLX9zt-kvxIOBqgadk4O-JrWpR4yuCVFX2ups3fwD64yeZ priority: 102 providerName: ProQuest |
Title | Effects of a 3-Week In-Hospital Body Weight Reduction Program on Cardiovascular Risk Factors, Muscle Performance, and Fatigue: A Retrospective Study in a Population of Obese Adults with or without Metabolic Syndrome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32455545 https://www.proquest.com/docview/2406427085 https://www.proquest.com/docview/2407316468 https://www.proquest.com/docview/2511190801 https://pubmed.ncbi.nlm.nih.gov/PMC7284609 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1taxNBEB76AtIvotaX1BpGFEHo2Xvb3ZwgkpbGKqSEaDDfwt5mTkPjnSZ3YH6pf8fZe0lNrX66t7lluZlln2dv9hmA51rFZpp0pk5HkHRC8snRviFH6MgVmikX37bZFhfyfBR-GIvxFjT1O-sPuLyR2tl6UqPF_NXPH6u3PODfWMbJlP04LTzfynhHYht2eUaSloT1a5hfwWDFdD2o1EmvvbIHtxhTCJ5VxebU9BfevJ42-cc81LsDt2sAid3K43dhi9J7sN9NmTx_W-ELLFM6y7XyffhVaRMvMUtQY-BYaV58nzpNsRA8yaYr_FyujuLQirhaN-GgytlCPj3dSFfF4Wx5ib2qRM8R9osldwEHV3sPjlCnUzbIZ18Keo1dbjRfZM1uTrRJiyucpdyZwbpwmO2cLU9A2LVaIEu0S8OYLcpjVuTYp5wjdT4z-LGWV7gPo97Zp9Nzp67k4BgGPLkjiVQgQ0Midr1Ek0i01ElgSLqmQ8wAtVL8WQOyG2uF8EXHE0nIwJ9cHWsRBg9gJ81SegRIilxPS2NiqUITxTHzuURyI1HAhyhswcvGiRNTy5zbahvzCdMd6_vJle9b8Gxt-70S97jR6rCJhUkTnxMLhEJfMWBtwdP1Yx6a9n-LTikrShtbFyyUnf_YMOBlTMY4oQUPq_Bad6WJyxaojcBbG1hp8M0n6exrKRGuGHVINzr4Z5uPYc-3KweucHzvEHbyRUFPGF7lcRu21Vi1Yffk7GIw5Kt3Y69djqffY48rZA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2V9AFeEFAugQKDuEhIterbrmMkhNLSKKFNFIVW9M2s12uIKHaJbaH8FL_D7zDjWxpAfeuTLXu0Xmlmd8-MZ84w9kJ6oYriXmT0uBaGq21tSFtpg0vf5BJdLnxM2RYTMTxxP5zy0w32q6mFobTKZk8sN-ooVRQj36WTx7U9RAjvzn8Y1DWK_q42LTQqszjUy5_osmVvR-9Rvy9te3BwvD806q4ChsLDNzeE1p4jXKV5aFqx1DyWQsaO0sJUPY3eiPS8SGlHU5En5zbvWTx2EYRqU4aSuw6Oe41tulTR2mGbeweT6ayN6pTsOcKpeFAdxzd3k8KyiWOcGlhcPPn-gbN_Z2VeOOYGt9jNGp9CvzKo22xDJ3fYVj9B3_z7El5BmTFahuK32O-K-jiDNAYJjkHMvzBKjKYXCeyl0RI-lcFXmBFHLFkBTKuUMMDb_bVsWJjNs28wqDoA7cC4yHAKMF2VNuyATCIUyOdfCv0G-jhovkibYlGgnMglzBOczLTtS0aTo-4HGvpENZIBRZ4hXZTXtMhhrHNcCGdzBR9r9oa77ORKVHqPdZI00Q8YaE-blhRKhcJzlR-G6C7GAgfxHbz4bpe9bpQYqJpFnZp5nAXoTZHCg5XCu-x5K3tecYf8V2q7sYWg3j-yYGXtXfasfY0rn37nyESnRSlDbcdc0btEBvE0Qj6EIV12vzKvdioIpTmCSfyCt2Z4rQAxj6-_SeZfSwZyD0GNMP2Hl0_9Kbs-PB4fBUejyeEjdsOmSIXJDdvaZp18UejHCOfy8Em9hoB9vupl-wciu2Ui |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF2VVEK8IKBcAgUGcZGQuopje9cxEkLpJWopjaJA1b6Z9XoNEcUusS2UX-NH-B1mfEsDqG99smWP1iPN7O6Z8ewZxl4oL9RRPIj4QBjJXWMbrmxtuFC-JRSGXPiYqi3Gcv_YfX8qTtfYr-YsDJVVNmtiuVBHqaYceY92Htf2ECH04rosYrI7enf-g1MHKfrT2rTTqFzk0Cx-YviWvT3YRVu_tO3R3qedfV53GOAaN-KcS2M8R7raiNDqx8qIWEkVO9pISw8MRibK8yJtHEMHPoWwxaAvYhcBqbFUqITr4LjX2LpHunXY-vbeeDJtMzwlk450Kk5Ux_GtXlL0beIbp2YWF3fBf6Dt3xWaF7a80S12s8aqMKyc6zZbM8kdtjFMME7_voBXUFaPlmn5Dfa7okHOII1BgcOJBRgOEt70JYHtNFrASZmIhSnxxZJHwKQqDwO83VmpjIXpLPsGo6ob0BYcFRmqAJPlMYctUEmEAvnsS2HewBAHzedpc3AUqD5yAbMElZm0PcpIOeqEYGBItCMZUBYa0nl5TYscjkyOk-JspuFjzeRwlx1fiUnvsU6SJuYBA-MZq6-k1qH0XO2HIYaOscRBfAcvvttlrxsjBrpmVKfGHmcBRlZk8GBp8C573sqeVzwi_5XabHwhqNeSLFh6fpc9a1_jKkC_dlRi0qKUoRZkrhxcIoPYGuEfQpIuu1-5V6sKwmqBwBK_4K04XitALOSrb5LZ15KN3EOAIy3_4eWqP2XXcboGHw7Gh4_YDZuSFpbgdn-TdfJ5YR4jssvDJ_UUAvb5qmftH0o1aU4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+a+3-Week+In-Hospital+Body+Weight+Reduction+Program+on+Cardiovascular+Risk+Factors%2C+Muscle+Performance%2C+and+Fatigue%3A+A+Retrospective+Study+in+a+Population+of+Obese+Adults+with+or+without+Metabolic+Syndrome&rft.jtitle=Nutrients&rft.au=Rigamonti%2C+Antonello+E&rft.au=Cicolini%2C+Sabrina&rft.au=Caroli%2C+Diana&rft.au=De+Col%2C+Alessandra&rft.date=2020-05-21&rft.eissn=2072-6643&rft.volume=12&rft.issue=5&rft_id=info:doi/10.3390%2Fnu12051495&rft_id=info%3Apmid%2F32455545&rft.externalDocID=32455545 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon |